Status:
TERMINATED
The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors
Lead Sponsor:
University of Southern California
Conditions:
Cervical Prostaglandin EP3 Receptors
Pregnancy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effect of mifepristone on the expression of three cervical EP3 receptor isoforms (EP3-2, EP3-3 and EP3-6) in pregnant women ≤63 days gestational age.
Eligibility Criteria
Inclusion
- good general health
- ≥18 years old
- seeking termination of a viable intrauterine pregnancy of ≤63 days, without any evidence of a threatened or spontaneous abortion
Exclusion
- medical problems
- confirmed or suspected ectopic pregnancy
- having taken medications in the seven days prior to enrollment that would affect PG synthesis or metabolism of mifepristone
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01224509
Start Date
September 1 2004
End Date
March 1 2005
Last Update
October 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's and Children's Hospital, Reproductive Research Center
Los Angeles, California, United States, 90033